Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04528498 · ClinicalTrials.gov registry record

Embryo Health Study

A clinical trial of Infertility and Hereditary Diseases, sponsored by Genomic Prediction.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT04528498 is a study of Infertility and Hereditary Diseases that is actively recruiting participants, run by Genomic Prediction. The registered enrollment target is 500 participants, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04528498, a study of Infertility and Hereditary Diseases, is actively recruiting participants, sponsored by Genomic Prediction.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic counseling.

Interventions

  • OTHER Preimplantation Genetic Testing

Study Locations (1)

New Jersey

  • Genomic Prediction Clinical Laboratory - North Brunswick

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-12-01
Est. Completion 2025-12-01

Sponsor

Genomic Prediction

6 total trials

What the Registry Record Tells You About NCT04528498

The ClinicalTrials.gov registry entry for NCT04528498 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (93% lower). The listed sponsor is Genomic Prediction, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Preimplantation Genetic Testing is the first listed.

NCT04528498 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04528498 about?

NCT04528498 is a clinical study titled "Embryo Health Study". This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of the...

What is the current status of trial NCT04528498?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-12-01. Estimated completion is 2025-12-01.

What conditions does trial NCT04528498 study?

This clinical trial studies the following conditions: Infertility, Hereditary Diseases.

What interventions are being tested in trial NCT04528498?

The interventions under investigation include: Preimplantation Genetic Testing (OTHER).

Who is sponsoring clinical trial NCT04528498?

This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04528498 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.